Alcon (ALC) announced the U.S. launch of Clareon TruPlus, its new enhanced design monofocal and toric intraocular lens, at the American Society of Cataract and Refractive Surgery Annual Meeting in Washington, D.C. TruPlus expands Alcon’s leading Clareon portfolio, offering surgeons an enhanced design IOL, enabling increased depth of focus without compromising the high-quality distance vision they expect from a monofocal IOL. Based on bench data, TruPlus has a number of differentiating features over Clareon Monofocal and the leading competitor IOL: TruPlus demonstrates a 3.5 letter improvement in simulated visual acuity at -1.5 diopters compared to Clareon Monofocal. TruPlus offers higher distance image quality than TECNIS Eyhance across a range of pupil sizes and lighting conditions. TruPlus exceeds the ISO upper requirement for distance image quality. TruPlus demonstrates a lower glare and halo profile than TECNIS Eyhance. TruPlus leverages proprietary Opti-Balance Technology in the center of the lens to slightly extend the depth of focus.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Alcon Sets April 30, 2026 AGM, Proposes New Director and CHF 0.28 Dividend
- Sight Sciences awarded monetary damages by district court against Alcon
- Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
- Lensar upgraded to Buy from Neutral at BTIG
- Lensar down 23% following termination of merger agreement with Alcon
